Navigation Links
Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
Date:11/6/2009

- 192,287 --------- --------- --------- --------- Net (loss) $(382,121) $(214,008) $(1,415,906) $(1,479,029) ========= ========= =========== =========== Basic and diluted net loss per share $(0.06) $(0.04) $(0.23) $(0.25) ====== ====== ====== ====== Shares used in computation of basic and diluted net loss per share 6,075,758 5,976,937 6,034,301 5,803,497 ========= ========= ========= ========= BioSpecifics Technologies Corporation Selected Consolidated Balance Sheet Data (Unaudited) September 30, December 31, 2009 2008 ---- ---- Cash and cash equivalents $4,267,591 $3,494,150 Short term investments 5,022,854 900,000 Accounts and income tax receivable, net 1,482,616 6,952,781 Working capital 9,157,129 9,422,245 Total assets 12,337,717 12,831,361 Long-term liabilities 4,321,154 4,660,427 Total stockholders' equity 6,394,870 6,178,539

SOURCE BioSpecifics Technologies Corp.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
4. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
5. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
6. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
7. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
9. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
10. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
11. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...hanghaiBiolaxyannouncedthe,ChineseStateFood&Dr...alnewdrugapplication(IND)foritsoralinsulinproject,...etes.ThisIND,approvalallowsBiolaxytoinitiateitsfir...haracteristicofhighbloodglucoseandpoor,metabolism....-and,macro-vasculardiseases,lossofvision,kidneyfai...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...s Service (CAS), the global expert on chemical inf...w the world,s leading producer of patent invention...patent office, the World Intellectual Property Org... Trademark Office (USPTO) for more than a decade, ...ceeded Japan for the first time on a monthly basis...
(Date:11/23/2009)...rbon layer in which the carbon atoms are arranged ...rbon nanotubes are rolled-up sheets of graphene, a...raphene boasts some very special characteristics ...al conductor, and reconciles such conflicting qual...raphene is impermeable to gases, which makes it in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2
...Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) ...chow, Krause & Company, LLP as its independent...diately. The decision to change the Company,s inde...oved by the Company,s board of directors. The app... , , Virchow Krause is the nation,s 17th largest ...
...RNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN...daq Staff Deficiency Letter on January 13, 2009, i... independent director requirement as set forth in ...he letter was a result of the resignation of a Dir..., 2009 press release. Following the receipt of the...
...ent in Brussels to bring together community around... , Brussels, Belgium (PRWE...e first annual OpenClinica European Summit. The ev...lgium and bring together users, developers, and le...urce electronic data capture (EDC) software ., , ...
Other Biology Technology:Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm 2Vasogen Complies with NASDAQ Marketplace Rule 4350(c)(1) 2Registration Open for OpenClinica European Summit - April 14, 2009 2
(Date:11/23/2009)...A new study by the Wildlife Conservation Society s...e swamp in the Republic of Congopart of the "mothe...ast yearare becoming increasingly threatened by gr... recommends protection of the swamp forests adjace...erve after recent surveys confirmed that high dens...
(Date:11/23/2009)...CHAMPAIGN, Ill. A new study provides "incontrover...f Toba on the island of Sumatra about 73,000 years...miles from the epicenter, researchers report. , ...ers of ash into the atmosphere, leaving a crater (... kilometers long and 35 kilometers wide. Ash from ...
(Date:11/23/2009)...DISON, WI, November 16, 2009 -- A USDOE and USDA s...and, idle cropland, and cropland pasture could be ...erennial grasses, such as switchgrass, from which ...edstock. Economically viable production of a peren...tities of biomass are removed annually is expected...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2Maimonides Medical Center Turns to Verizon to Boost Security of Health Care Data 54469 1Maimonides Medical Center Turns to Verizon to Boost Security of Health Care Data 54469 2Maimonides Medical Center Turns to Verizon to Boost Security of Health Care Data 54469 3Maimonides Medical Center Turns to Verizon to Boost Security of Health Care Data 54469 4Maimonides Medical Center Turns to Verizon to Boost Security of Health Care Data 54469 5China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 1China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 2China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 3China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 4Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 54466 1Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 54466 2Bed Bug Epidemic and Upcoming School Breaks Could Wreak Havoc on Homeowners 54466 3
...s vinifera) is a widely cultivated crop that has b...ithic period (from ~10,500 to ~6,000 years ago). T...ction for traits important for its cultivation and...grapevine genome has opened the possibility for an... has shown that genes constitute only a very small...
... of dams and other impoundments is increasing the ...they spread, putting natural lakes at risk, says a...r. , The research team combined data on water che...s" and boating activity from the Great Lakes regio...f such species in impoundments creates "stepping-s...
...Broad Institute of Harvard and MIT today announced... ~ $86M grant from the National Institutes of Heal...nown as "small molecules", which can probe the pro...hat are crucial to human health and disease. The B...ve funding under the Molecular Libraries and Imagi...
Other Biology News:Biological invasions increasing due to freshwater impoundments, says CU-Boulder study 2Biological invasions increasing due to freshwater impoundments, says CU-Boulder study 3Broad Institute awarded grant to develop chemical probes for human biology and disease 2Broad Institute awarded grant to develop chemical probes for human biology and disease 3
Rabbit Anti-Wilm's tumor Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-p27 Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-UBC13 Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone
Biology Products: